Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Diisopropylcarbodiimide M930063

 

CASRN: 693-13-0

Formula: C7-H14-N2

Synonyms/Common Names

  • DIC
  • 1,3-Diisopropylcarbodiimide
  • N,N'-Diisopropylcarbodiimide

Known Uses

As a peptide coupling reagent; as a condensing reagent in dipeptide synthesis; in preparation of polyimide precursor coatings for electrophoretic image display fabrication; as a military nerve agent stabilizer.

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 2 weeks (Topical Application)  (C93020)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R&M: 0, 10, 30, 90, 269, OR 806 MG/ML; 5/SEX/SPECIES/GROUP.
  • 20 weeks (Topical Application)  (C93020B)  Completed 
    • GMM-10 (NIH Number: 07-4427)  (Peer Review Approval 09/28/2005A )
      Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient Mice (Dermal Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: FEMALE MICE: 0, 4.38, 8.75, 17.5, 35, OR 70 MG/KG; 10/GROUP.
  • 27 weeks (Topical Application)  (C93020C)  Completed 
    • GMM-10 (NIH Number: 07-4427)  (Peer Review Approval 09/28/2005A )
      Toxicology Study of Diispropylcarbodiimide (CASRN 693-13-0) in Genetically Modified (FVB Tg.AC Hemizygous) Mice and Carcinogenicity Study of Diispropylcarbodiimide in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient Mice (Dermal Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: FEMALE MICE: 0, 4.38, 8.75, 17.5, 35, OR 70 MG/KG; 15/GROUP.
  • 13 weeks (Topical Application)  (C93020)  Completed 
    • Rats: F344/N; Mice: B6C3F1
    • Dose: R: 0, 10, 20, 40, 80, OR 160 MG/KG M: 0, 17.5, 35, 70, 140, OR 280 10 SEX/SPECIES/GROUP, 6 GROUPS.

Long-Term Carcinogenicity

  • 2 years (Topical Application)  (C93020D)  Completed 
    • TR-523 (NIH Number: 07-4473)  (Peer Review Approval 09/28/2005A )
      Toxicology and Carcinogenesis Studies of Diisopropylcarbodiimide (CASRN 693-13-0) in F344/N Rats and B6C3F1 Mice (Dermal Studies)
    • Rats: F344/N; Mice: B6C3F1
    • Carcinogenesis Results
      • Male Rats No Evidence 
      • Female Rats No Evidence 
      • Male Mice No Evidence 
      • Female Mice No Evidence 
    • Dose: R&M: 0, 10, 20, OR 40 MG/KG; 50/SEX/SPECIES.

Special Studies

  • Absorption Disposition Metabolism Elimination (Intravenous; Topical Application)  (S0662)  Completed 
    • Citation: Disposition of Dermally and Intravenously Administered [14C]Dicyclohexylcarbodlimide in Fischer 344 Rats and B6C3F1 Mice January 4, 1999
    • Male Rats: F344/N; Male Mice: B6C3F1
    • Dose: dermal: 4-42 mg/kg (rats); 7-82 mg/kg (mice) IV: 8 mg/kg (dose vol. 1.3 ml/kg) (mice-only) for dermal needed to use charcoal-impregnated cellulose filters.

Genetic Toxicology

  • Micronucleus  (A04322)  Completed 
    • Citation: Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. Induction of Micronucleated Erythrocytes in Rodents by Diisopropylcarbodiimide and Dicyclohexylcarbodiimide: Dependence on Exposure Protocol. Environ. Molec. Mutag. Vol. 33 (1999) 65-74
    • Mice: B6C3F1
    • Male Equivocal 
  • Micronucleus  (A22799)  Completed 
    • Citation: Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. Induction of Micronucleated Erythrocytes in Rodents by Diisopropylcarbodiimide and Dicyclohexylcarbodiimide: Dependence on Exposure Protocol. Environ. Molec. Mutag. Vol. 33 (1999) 65-74
    • Mice: B6C3F1
    • Male Positive 
    • Female Positive 
  • Micronucleus  (A55884)  Completed 
    • Citation: Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. Induction of Micronucleated Erythrocytes in Rodents by Diisopropylcarbodiimide and Dicyclohexylcarbodiimide: Dependence on Exposure Protocol. Environ. Molec. Mutag. Vol. 33 (1999) 65-74
    • Mice: B6C3F1
    • Male Positive 
  • Micronucleus  (A76999)  Completed 
    • Citation: Witt, K.L., Tice, R.R., Shelby, M.D., Chhabra, R.S., and Zeiger, E. Induction of Micronucleated Erythrocytes in Rodents by Diisopropylcarbodiimide and Dicyclohexylcarbodiimide: Dependence on Exposure Protocol. Environ. Molec. Mutag. Vol. 33 (1999) 65-74
    • Rats: Fischer 344
    • Male Negative 
  • Salmonella  (A69920)  Completed 
    •  Equivocal 
  • Salmonella  (A92772)  Completed 
    •  Negative 

Organ Systems Toxicity

  • 4 days Immunotoxicity (Topical Application)  (IMM95010)  Completed 
    • Female Mice: B6C3F1
    • Dose: .03, .15, .3, 1.5, AND 3% DIC IN ACETONE (99.8%) FOR SENSIZATION, AND 10% DIC FOR CHALLENGE IN THE MEST AND 1.5, 3 AND 10% DIC IN THE LLNA. .25% DNFB USED AS POSITIVE CONTROL FOR SENSITIZATION, AND .5% FOR CHALLENGE..